CHICAGO (CN) - A generic version of the antibiotic Biaxin made a police officer psychotic, believe himself a prophet, and open fire on firefighters trying to help him because he thought they were ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) has issued a warning advising prescribers to practice caution before prescribing the common ...

ABBOTT PARK, Ill., Aug. 6, 2001 – Abbott Laboratories announced today it has received U.S. Food and Drug Administration (FDA) approval of a new seven-day indication for Biaxin(R) XL (clarithromycin ...

Previous studies of Biaxin, known generically as clarithromycin, as well as similar drugs have not detected any increase in deaths. “A mechanism by which two weeks of clarithromycin could cause ...

Trial CL-05 Results Showed Cethromycin had 94.0% Clinical Cure Rate Compared to 93.8% Clinical Cure Rate for Biaxin(R), a Current Standard of Care Treatment Trial CL-05 and Trial CL-06 to Form the ...

Generic drugmaker Teva Pharmaceutical Industries has halted sales of its new antibiotic product clarithromycin in the USA after another legal salvo from the drug’s originator Abbott Laboratories.

Teva Pharmaceutical Industries Ltd., the world’s biggest generic-drug company, and North Chicago-based Abbott Laboratories agreed to settle a patent lawsuit over the antibiotic Biaxin XL on Tuesday.

Abbott Laboratories Friday won an appeals court ruling stopping Andrx Pharmaceuticals from selling generic versions of its antibiotic Biaxin XL until a patent suit is resolved. The US Court of Appeals ...

Israel’s Teva Pharmaceutical Industries, currently jostling with Sandoz for the top slot in the global generics sector, and US firm Ivax Laboratories have been granted final approval for two ...

Biaxin contains an active ingredient called Clarithromycin. It belongs to the class of antibiotics called macrolides. Biaxin Clarithromycin is a semisynthetic macrolide antibiotic. It acts by ...

WASHINGTON -- The Food and Drug Administration issued an alert Friday involving Biaxin, an antibiotic made by Abbott Laboratories. The agency issued an alert to patients and health care professionals ...